comparemela.com

Latest Breaking News On - Mali zeevi - Page 1 : comparemela.com

BioLineRx Ltd (NASDAQ:BLRX) Q1 2024 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx First Quarter 2024 Financial Results Conference Call. All participants are presently in a listen-only mode.

United statesJohn vandermostenJohn laceyGloria biosciencesPhil serlinElla soraniJoe pantginisAmerican society for apheresis annual meetingBiolinerx ltdCorporate communicationsWashington universityColumbia universityOutcomes researchExchange commissionInternational society for pharmacoeconomicsAmerican society of clinical oncology

BioLineRx : FORM S-8-registration of Ordinary Shares to be issued under the Plan -December 31, 2023 at 03:01 am EST

As filed with the Securities and Exchange Commission on December 29, 2023. Registration No. 333- UNITED STATES .

Israel generalUnited statesNew yorkTel avivState of israelSharon rosenRaphael hofsteinAdamd janoffAvraham molchoPhil serlinShaoyu yanPhilipa serlinGal cohenMichaelj anghelAharon schwartzGary emmanuel

BioLineRx Ltd (NASDAQ:BLRX) Q3 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Third Quarter 2023 Financial Results Conference Call. All participants are presently in a listen-only mode.

United statesGloria biosciencesJoe pantginisElla soraniPhil serlinJohn laceyColumbia universityUs researchOil producing countriesExchange commissionCorporate communicationsAmerican societyWashington university school of medicineBiolinerx ltdCall transcript novemberBiolinerx third quarter

BioLineRx Ltd (NASDAQ:BLRX) Q2 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Second Quarter 2023 Financial Results Conference Call. All participants are presently in listen-only mode.

Hong kongUnited statesElla soraniPhil serlinJoe pantginisJohn laceyColumbia universityIsraeli innovation authorityWashington university school of medicineHead of investor relations and corporate communicationsBiolinerx ltdCall transcript augustBiolinerx second quarterResults conferenceInvestor relations and corporateChief executive officer

BioLineRx Ltd (NASDAQ:BLRX) Q1 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx First Quarter 2023 Financial Results Conference Call.

Kevin campbellPhil serlinEric sappMark breidenbachGenzyme sanofiJoe pantginisJohn laceyElla soraniTami rachmilewitzPhilip serlinJohn vandermostenCorporate communications biolinerxWashington university school of medicineColumbia universityMarket developmentProgram scientific advisory board

vimarsana © 2020. All Rights Reserved.